← Drug-vs-drug verdicts

Rybelsus vs Ozempic: Same Molecule, Tablet or Injection

Rybelsus (semaglutide (oral), Novo Nordisk) vs Ozempic (semaglutide (subcutaneous), Novo Nordisk)

Last verified May 2026

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

The verdict

Identical drug, two delivery routes, and the route is the whole difference. Ozempic is injected weekly; Rybelsus is a daily tablet requiring a strict fast before and after, because the SNAC absorption enhancer only works on an empty stomach. On outcomes, SUSTAIN-6 showed superiority for MACE (HR 0.74) while PIONEER 6 showed non-inferiority (HR 0.79). Retail is around $1,029 and $998. Choose on whether a daily fasting routine or a weekly needle fits your life better.

Side-by-side comparison

FieldRybelsusOzempic
Route & frequencyOral tablet, once daily (empty stomach)Subcutaneous injection, once weekly
FDA-approved dose range3 mg → 7 mg → 14 mg daily0.25 → 0.5 → 1 → 2 mg weekly
A1C reduction (monotherapy)−0.9% to −1.4% / 26 wk (PIONEER 1, 14 mg)−1.4% to −1.6% / 30 wk (SUSTAIN 1, 1 mg)
Head-to-head vs injectable GLP-1Oral sema 14 mg −1.2% A1C; liraglutide 1.8 mg −1.1% (PIONEER 4)Not the comparator in PIONEER 4 (oral vs liraglutide)
Weight loss (max dose)−4.4 kg at 26 wk (PIONEER 1, 14 mg)−4.5 to −6.5 kg at 30-40 wk (SUSTAIN program, 1-2 mg)
Cardiovascular outcome trialMACE HR 0.79 (NS, non-inferior; PIONEER 6)MACE HR 0.74 (superior; SUSTAIN-6)
MechanismGLP-1 receptor agonist (semaglutide + SNAC absorption enhancer)GLP-1 receptor agonist (semaglutide)
What it costs if you pay cashAbout $1,029/mo retailAbout $998/mo retail

What each one costs in the compounded market

Standing monthly cash prices from the 556 sellers on this register. These are compounded preparations, not the approved products compared above.

Rybelsussemaglutide (oral)

from $79 /mo

283 sellers publish a standing price; the median is $174 a month.

Ozempicsemaglutide (subcutaneous)

from $79 /mo

283 sellers publish a standing price; the median is $174 a month.

⚠ A compounded preparation is not the approved product. No agency has reviewed that specific preparation for safety, effectiveness or manufacturing quality, and the legal ground under compounding these molecules narrowed when the shortages closed. The price gap is real, and so is the difference in oversight. Every seller, with its price record.

Frequently asked questions

Which works better for weight loss, Rybelsus or Ozempic?

On the trial evidence, Ozempic. Rybelsus recorded −4.4 kg at 26 wk (PIONEER 1, 14 mg) and Ozempic −4.5 to −6.5 kg at 30-40 wk (SUSTAIN program, 1-2 mg), and the head-to-head comparison put Rybelsus at Oral sema 14 mg −1.2% A1C; liraglutide 1.8 mg −1.1% (PIONEER 4) against Ozempic at Not the comparator in PIONEER 4 (oral vs liraglutide). A head-to-head is the strongest form of this evidence because both arms run under one protocol — separate trials are not directly comparable however alike they look.

Are Rybelsus and Ozempic the same drug?

Chemically, yes — both are semaglutide (oral). They are sold under different names for different approved uses, and usually at different doses and different prices. That is a labeling and commercial distinction, not a pharmacological one, which is why a prescription for one is not automatically interchangeable with the other at the pharmacy counter.

Is Rybelsus or Ozempic cheaper?

On the manufacturers' own cash pricing: Rybelsus at About $1,029/mo retail, Ozempic at About $998/mo retail. ⚠ That is the list-price comparison, and it is not what most people pay. What you actually pay depends on whether your plan covers it, which formulary tier it sits in, and whether you have met your deductible — and for many people the honest comparison is between an insured copay and a cash-pay compounded alternative rather than between these two figures.

Does either one have better cardiovascular evidence?

Ozempic does. Rybelsus: MACE HR 0.79 (NS, non-inferior; PIONEER 6). Ozempic: MACE HR 0.74 (superior; SUSTAIN-6). This matters more than it first appears — a drug with a completed outcomes trial has evidence about events that matter, not only about weight, and that is often what decides coverage.

What does a compounded version of each actually cost?

Across the 556 sellers in this register, the cheapest standing monthly cash prices we hold are semaglutide (oral) from $79 a month and semaglutide (subcutaneous) from $79 a month. ⛔ A compounded preparation is not the approved product: no agency has reviewed that specific preparation for safety, effectiveness or manufacturing quality, and the legal ground under compounding these molecules narrowed once the shortages closed. The price gap is real and so is the difference in oversight.

Can I switch from Rybelsus to Ozempic?

People move between them regularly, since it is the same molecule — but the dose ladders differ, so a prescriber has to map where you land rather than matching the number. Do not assume your current dose transfers.

Which one should I ask for?

That is a prescriber's call, and anyone answering it from a table is guessing. What a page like this can do is tell you what the trials measured, what the manufacturers charge, and where the evidence is still missing, so the conversation starts from the record rather than from an advertisement.

References

  1. 1.Aroda VR, Rosenstock J, Terauchi Y, et al. PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes. Diabetes Care. 2019. PMID: 31186300.
  2. 2.Pratley R, Amod A, Hoff ST, et al. Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial. Lancet. 2019. PMID: 31186120.
  3. 3.Husain M, Birkenfeld AL, Donsmark M, et al. Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (PIONEER 6). N Engl J Med. 2019. PMID: 31185157.
  4. 4.Marso SP, Bain SC, Consoli A, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). N Engl J Med. 2016. PMID: 27633186.
  5. 5.Novo Nordisk. RYBELSUS (semaglutide) oral tablet — Prescribing Information. DailyMed (NIH/NLM). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98
  6. 6.Novo Nordisk. OZEMPIC (semaglutide) injection — Prescribing Information. DailyMed (NIH/NLM). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79

Related comparisons

See the full drug-vs-drug verdict index or provider rankings.